329 related articles for article (PubMed ID: 20112359)
1. Genetic variation at the IRF7/PHRF1 locus is associated with autoantibody profile and serum interferon-alpha activity in lupus patients.
Salloum R; Franek BS; Kariuki SN; Rhee L; Mikolaitis RA; Jolly M; Utset TO; Niewold TB
Arthritis Rheum; 2010 Feb; 62(2):553-61. PubMed ID: 20112359
[TBL] [Abstract][Full Text] [Related]
2. IRF5 haplotypes demonstrate diverse serological associations which predict serum interferon alpha activity and explain the majority of the genetic association with systemic lupus erythematosus.
Niewold TB; Kelly JA; Kariuki SN; Franek BS; Kumar AA; Kaufman KM; Thomas K; Walker D; Kamp S; Frost JM; Wong AK; Merrill JT; Alarcón-Riquelme ME; Tikly M; Ramsey-Goldman R; Reveille JD; Petri MA; Edberg JC; Kimberly RP; Alarcón GS; Kamen DL; Gilkeson GS; Vyse TJ; James JA; Gaffney PM; Moser KL; Crow MK; Harley JB
Ann Rheum Dis; 2012 Mar; 71(3):463-8. PubMed ID: 22088620
[TBL] [Abstract][Full Text] [Related]
3. Association of the IRF5 risk haplotype with high serum interferon-alpha activity in systemic lupus erythematosus patients.
Niewold TB; Kelly JA; Flesch MH; Espinoza LR; Harley JB; Crow MK
Arthritis Rheum; 2008 Aug; 58(8):2481-7. PubMed ID: 18668568
[TBL] [Abstract][Full Text] [Related]
4. Association of a functional IRF7 variant with systemic lupus erythematosus.
Fu Q; Zhao J; Qian X; Wong JL; Kaufman KM; Yu CY; ; ; Mok MY; Harley JB; Guthridge JM; Song YW; Cho SK; Bae SC; Grossman JM; Hahn BH; Arnett FC; Shen N; Tsao BP
Arthritis Rheum; 2011 Mar; 63(3):749-54. PubMed ID: 21360504
[TBL] [Abstract][Full Text] [Related]
5. Network analysis of associations between serum interferon-α activity, autoantibodies, and clinical features in systemic lupus erythematosus.
Weckerle CE; Franek BS; Kelly JA; Kumabe M; Mikolaitis RA; Green SL; Utset TO; Jolly M; James JA; Harley JB; Niewold TB
Arthritis Rheum; 2011 Apr; 63(4):1044-53. PubMed ID: 21162028
[TBL] [Abstract][Full Text] [Related]
6. Association of PHRF1-IRF7 region polymorphism with clinical manifestations of systemic lupus erythematosus in a Japanese population.
Kawasaki A; Furukawa H; Kondo Y; Ito S; Hayashi T; Kusaoi M; Matsumoto I; Tohma S; Takasaki Y; Hashimoto H; Sumida T; Tsuchiya N
Lupus; 2012 Jul; 21(8):890-5. PubMed ID: 22433914
[TBL] [Abstract][Full Text] [Related]
7. Novel identification of the IRF7 region as an anticentromere autoantibody propensity locus in systemic sclerosis.
Carmona FD; Gutala R; Simeón CP; Carreira P; Ortego-Centeno N; Vicente-Rabaneda E; García-Hernández FJ; García de la Peña P; Fernández-Castro M; Martínez-Estupiñán L; Egurbide MV; Tsao BP; Gourh P; Agarwal SK; Assassi S; Mayes MD; Arnett FC; Tan FK; Martín J;
Ann Rheum Dis; 2012 Jan; 71(1):114-9. PubMed ID: 21926187
[TBL] [Abstract][Full Text] [Related]
8. The autoimmune disease risk allele of UBE2L3 in African American patients with systemic lupus erythematosus: a recessive effect upon subphenotypes.
Agik S; Franek BS; Kumar AA; Kumabe M; Utset TO; Mikolaitis RA; Jolly M; Niewold TB
J Rheumatol; 2012 Jan; 39(1):73-8. PubMed ID: 22045845
[TBL] [Abstract][Full Text] [Related]
9. Comparison of autoantibody specificities between traditional and bead-based assays in a large, diverse collection of patients with systemic lupus erythematosus and family members.
Bruner BF; Guthridge JM; Lu R; Vidal G; Kelly JA; Robertson JM; Kamen DL; Gilkeson GS; Neas BR; Reichlin M; Scofield RH; Harley JB; James JA
Arthritis Rheum; 2012 Nov; 64(11):3677-86. PubMed ID: 23112091
[TBL] [Abstract][Full Text] [Related]
10. Neutrophil Extracellular Trap Mitochondrial DNA and Its Autoantibody in Systemic Lupus Erythematosus and a Proof-of-Concept Trial of Metformin.
Wang H; Li T; Chen S; Gu Y; Ye S
Arthritis Rheumatol; 2015 Dec; 67(12):3190-200. PubMed ID: 26245802
[TBL] [Abstract][Full Text] [Related]
11. The potential role of interferon-regulatory factor 7 among Taiwanese patients with systemic lupus erythematosus.
Lin LH; Ling P; Liu MF
J Rheumatol; 2011 Sep; 38(9):1914-9. PubMed ID: 21632682
[TBL] [Abstract][Full Text] [Related]
12. Autoimmune disease risk variant of IFIH1 is associated with increased sensitivity to IFN-α and serologic autoimmunity in lupus patients.
Robinson T; Kariuki SN; Franek BS; Kumabe M; Kumar AA; Badaracco M; Mikolaitis RA; Guerrero G; Utset TO; Drevlow BE; Zaacks LS; Grober JS; Cohen LM; Kirou KA; Crow MK; Jolly M; Niewold TB
J Immunol; 2011 Aug; 187(3):1298-303. PubMed ID: 21705624
[TBL] [Abstract][Full Text] [Related]
13. Large-scale analysis of tumor necrosis factor α levels in systemic lupus erythematosus.
Weckerle CE; Mangale D; Franek BS; Kelly JA; Kumabe M; James JA; Moser KL; Harley JB; Niewold TB
Arthritis Rheum; 2012 Sep; 64(9):2947-52. PubMed ID: 22488302
[TBL] [Abstract][Full Text] [Related]
14. Association of genetic variations in the STAT4 and IRF7/KIAA1542 regions with systemic lupus erythematosus in a Northern Han Chinese population.
Li P; Cao C; Luan H; Li C; Hu C; Zhang S; Zeng X; Zhang F; Zeng C; Li Y
Hum Immunol; 2011 Mar; 72(3):249-55. PubMed ID: 21167895
[TBL] [Abstract][Full Text] [Related]
15. Low CD4 + T cell count is related to specific anti-nuclear antibodies, IFNα protein positivity and disease activity in systemic lupus erythematosus pregnancy.
Torell A; Stockfelt M; Blennow K; Zetterberg H; Akhter T; Leonard D; Rönnblom L; Pihl S; Saleh M; Sjöwall C; Strevens H; Jönsen A; Bengtsson AA; Trysberg E; Majczuk Sennström M; Zickert A; Svenungsson E; Gunnarsson I; Bylund J; Jacobsson B; Rudin A; Lundell AC
Arthritis Res Ther; 2024 Mar; 26(1):65. PubMed ID: 38459582
[TBL] [Abstract][Full Text] [Related]
16. Anti-ribosomal P antibodies are associated with elevated circulating IFNα and IL-10 levels in systemic lupus erythematosus patients.
Mozo L; López P; Caminal-Montero L; Rodríguez-Carrio J; Suárez A
Lupus; 2014 Dec; 23(14):1477-85. PubMed ID: 25107939
[TBL] [Abstract][Full Text] [Related]
17. Distinct autoantibody profiles in systemic lupus erythematosus patients are selectively associated with TLR7 and TLR9 upregulation.
Chauhan SK; Singh VV; Rai R; Rai M; Rai G
J Clin Immunol; 2013 Jul; 33(5):954-64. PubMed ID: 23564191
[TBL] [Abstract][Full Text] [Related]
18. Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease.
Kirou KA; Lee C; George S; Louca K; Peterson MG; Crow MK
Arthritis Rheum; 2005 May; 52(5):1491-503. PubMed ID: 15880830
[TBL] [Abstract][Full Text] [Related]
19. Interferon regulatory factors in human lupus pathogenesis.
Salloum R; Niewold TB
Transl Res; 2011 Jun; 157(6):326-31. PubMed ID: 21575916
[TBL] [Abstract][Full Text] [Related]
20. PTPN22 association in systemic lupus erythematosus (SLE) with respect to individual ancestry and clinical sub-phenotypes.
Namjou B; Kim-Howard X; Sun C; Adler A; Chung SA; Kaufman KM; Kelly JA; Glenn SB; Guthridge JM; Scofield RH; Kimberly RP; Brown EE; Alarcón GS; Edberg JC; Kim JH; Choi J; Ramsey-Goldman R; Petri MA; Reveille JD; Vilá LM; Boackle SA; Freedman BI; Tsao BP; Langefeld CD; Vyse TJ; Jacob CO; Pons-Estel B; ; Niewold TB; Moser Sivils KL; Merrill JT; Anaya JM; Gilkeson GS; Gaffney PM; Bae SC; Alarcón-Riquelme ME; ; Harley JB; Criswell LA; James JA; Nath SK
PLoS One; 2013; 8(8):e69404. PubMed ID: 23950893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
